Radiation Oncology/Therapy: Page 227

IsoRay touts Cleveland Clinic study
By AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical is touting a Cleveland Clinic study that found brachytherapy to have the fewest toxicities involving genital or urinary organs and the lowest total cost per patient, per year.
February 6, 2012
PET after radiation therapy predicts NSCLC survival
By Wayne Forrest
PET can provide strong indicators of overall and disease-free survival among patients with locally advanced non-small cell lung cancer (NSCLC) receiving radiation therapy, according to a study published in the February Journal of Nuclear Medicine.
February 2, 2012
2012 02 02 16 21 38 469 Nsclc Scans Jnm Thumb
Molecular Insight inks radiopharma deal
By AuntMinnie.com staff writers
Radiopharmaceutical developer Molecular Insight Pharmaceuticals has signed an agreement with the Centre for Probe Development and Commercialization to manufacture a new radiopharmaceutical designed to deliver therapeutic doses of radiation directly to metastatic prostate cancer.
January 30, 2012
Robotic IMRT-APBI works well for breast cancer patients
By Cynthia E. Keen
For qualified patients diagnosed with early-stage breast cancer, accelerated partial-breast irradiation (APBI) brachytherapy offers an abbreviated course of treatment. But APBI delivered by a robotic intensity-modulated radiotherapy (IMRT) system offers the additional advantage of being noninvasive.
January 30, 2012
PET/CT detects head/neck cancer recurrences earlier
By Cynthia E. Keen
Routine use of follow-up PET/CT scans can detect local cancer recurrences before they become clinically apparent, and may improve outcomes of subsequent salvage therapy, according to a study presented on Friday at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.
January 27, 2012
IMRT offers better outcome for head/neck cancer patients
By Cynthia E. Keen
Patients treated with intensity-modulated radiation therapy (IMRT) for head and neck cancer reported increasingly better quality of life after treatment than patients receiving other forms of radiotherapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.
January 26, 2012
Accuray touts CyberKnife study
By AuntMinnie.com staff writers
Radiation therapy firm Accuray said recent research found its CyberKnife robotic radiosurgery system to be beneficial in treating central lung tumors.
January 26, 2012
AuntMinnie.com Radiation Oncology Insider
By Cynthia E. Keen
January 25, 2012
HIV lowers RT response in head/neck cancer
By AuntMinnie.com staff writers
Radiation therapy with or without chemotherapy is less effective for HIV-positive than HIV-negative head and neck cancer patients in terms of recurrence and overall survival rates, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, which starts today in Phoenix.
January 25, 2012
Varian wins $77M Saudi proton contract
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems has booked a $77 million contract with a Saudi Arabian firm to equip a new proton therapy facility.
January 25, 2012
Oral HPV infection increasing in young men
By AuntMinnie.com staff writers
The incidence of oral human papillomavirus (HPV) infection, the principal cause of a form of oropharyngeal squamous cell carcinoma, is increasing in young men in the U.S., according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, which begins today in Phoenix.
January 25, 2012
Prostate brachytherapy reduces death rates of high-risk men
By Cynthia E. Keen
Prostate brachytherapy for high-risk prostate cancer patients has historically been considered a less effective treatment, but a new study of almost 13,000 men published online January 23 in the International Journal of Radiation Oncology, Biology, Physics suggests otherwise.
January 25, 2012
Previous Page
Page 227 of 467
Next Page